Oppenheimer Asset Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
CIP
FLAM
DSCM
Oppenheimer Asset Management's ATRC Position: Q3 2024 in Review
Oppenheimer Asset Management sold out of AtriCure (ATRC) in Q3 2024, closing a stake of 10,462 shares — an estimated $238K sold.
Oppenheimer Asset Management first reported a position in ATRC in Q4 2018 and held it in 23 quarters. The position peaked at $988K in Q2 2021. 201 funds tracked by Wall St. Rank hold ATRC as of Q3 2024.
- Oppenheimer Asset Management reported no remaining AtriCure position as of Q3 2024 after selling out during the quarter.
- Oppenheimer Asset Management sold 10,462 AtriCure shares in Q3 2024, an estimated $238K.
- Oppenheimer Asset Management first reported a position in AtriCure in Q4 2018 and held it in 23 quarters.
- Oppenheimer Asset Management's AtriCure position peaked at $988K in Q2 2021.
- 201 funds tracked by Wall St. Rank held AtriCure as of Q3 2024.
Based on Oppenheimer Asset Management's 13F filing for Q3 2024, filed 5 Nov 2024.